Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: Results of a prospective longitudinal pilot trial

Archives of Dermatological Research

Volumn 303, Issue 6, 2011, Pages 381-388

  Boehncke, Sandra ^a   Fichtlscherer, Stephan ^a   Salgo, Rebekka ^a   Garbaraviciene, Jurate ^a   Beschmann, Heike ^a   Diehl, Sandra ^a   Hardt, Katja ^a   Thaçi, Diamant ^a   Boehncke, Wolf Henning ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Adipokines; Comorbidities; Endothelial cell dysfunction; Insulin resistance; Myocardial infarction; Psoriasis

Indexed keywords

ACETYLCHOLINE; ADIPONECTIN; C REACTIVE PROTEIN; FUMARIC ACID ETHYL ESTER; GLUCOSE; INSULIN; NITROPRUSSIDE SODIUM; RESISTIN; SODIUM CHLORIDE; VASCULOTROPIN;

ADULT; AGED; CARDIOVASCULAR RISK; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; ENDOTHELIUM CELL; FEMALE; FOREARM BLOOD FLOW; HEART INFARCTION; HEART PROTECTION; HUMAN; INSULIN RESISTANCE; INSULIN RESPONSE; LONGITUDINAL STUDY; MALE; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PSORIASIS VULGARIS; REVIEW; SYSTEMIC THERAPY; THERAPY EFFECT; TREATMENT DURATION; VASODILATATION; VEIN OCCLUSION;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; FUMARATES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; PSORIASIS; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960746980     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-010-1108-6     Document Type: Review

References (46)

1. J Berth-Jones K Grotzinger C Rainville B Pham J Huang S Daly M Herdman P Firth K Hotchkiss 2006 A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment Br J Dermatol 155 707 713 16965419 10.1111/j.1365-2133.2006.07389.x 1:STN:280:DC%2BD28rktVGgsQ%3D%3D (Pubitemid 44352550)
2. W-H Boehncke S Boehncke MP Schön 2010 Managing comorbid disease in patients with psoriasis BMJ 340 b5666 20080817 10.1136/bmj.b5666
3. S Boehncke D Thaci H Beschmann RJ Ludwig H Ackermann K Badenhoop WH Boehncke 2007 Psoriasis patients show signs of insulin resistance Br J Dermatol 157 1249 1251 17916217 10.1111/j.1365-2133.2007.08190.x 1:STN:280: DC%2BD2snotl2qsQ%3D%3D (Pubitemid 350115673)
4. AA Cerman S Bozkrut A Sav A Tulunay MO Elbasi T Ergun 2008 Serum leptin levels, skin leptin and leptin receptor expression in psoriasis Br J Dermatol 159 820 826 18637894 10.1111/j.1365-2133.2008.08742.x 1:CAS:528: DC%2BD1cXhtlGitrvL
5. S Coimbra H Oliveira F Reis L Belo S Rocha A Quintanilha A Figueiredo F Teixeira E Castro P Rocha-Peraira A Santos-Silva 2010 C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy J Eur Acad Dermatol 24 789 796 10.1111/j.1468-3083.2009.03527.x 1:CAS:528:DC%2BC3cXotV2mu7c%3D
6. WG Dixon KD Watson M Lunt KL Hyrich the British Society for Rheumatology Biologics Register Control Centre Consortium 2007 Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register Arthritis Rheum 56 2905 2912 17763428 10.1002/art.22809 1:CAS:528:DC%2BD2sXht1GgtbzJ (Pubitemid 47502736)
7. S Fichtlscherer L Rossig S Breuer, et al. 2001 Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure Circulation 104 3023 3025 11748093 10.1161/hc5001.101749 1:CAS:528:DC%2BD38XptFymuw%3D%3D (Pubitemid 34014050)
8. S Fichtlscherer G Rosenberger DH Walter S Breuer S Dimmeler AM Zeiher 2000 Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease Circulation 102 1000 1006 10961964 1:CAS:528:DC%2BD3cXmslSksb0%3D (Pubitemid 30657516)
9. AY Finlay 2005 Current severe psoriasis and the rule of tens Br J Dermatol 152 861 867 15888138 10.1111/j.1365-2133.2005.06502.x 1:STN:280:DC%2BD2M3kvFSlsg%3D%3D (Pubitemid 40704922)
10. J Garbaraviciene S Diehl D Varwig M Bylaite H Ackermann RJ Ludwig WH Boehncke 2010 Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis Exp Dermatol 19 736 741 20482619 10.1111/j.1600-0625.2010.01095.x 1:CAS:528:DC%2BC3cXhtFWgs7bI
11. JM Gelfand AL Neimann DB Shin X Wang DJ Margolis AB Troxel 2006 Risk of myocardial infarction in patients with psoriasis JAMA 296 1735 1741 17032986 10.1001/jama.296.14.1735 1:CAS:528:DC%2BD28XhtVyjs77F (Pubitemid 44547793)
12. JM Gelfand AB Troxel JD Lewis SK Kurd DB Shin X Wang DJ Margolis BL Strom 2007 The risk of mortality in patients with psoriasis: results from a population-based study Arch Dermatol 143 1493 1499 18086997 10.1001/archderm. 143.12.1493 (Pubitemid 350277763)
13. P Gisondi F Fantin M Del Giglio F Valbusa F Marino M Zamboni G Girolomoni 2009 Chronic plaque psoriasis is associated with increased arterial stiffness Dermatology 218 100 103 10.1159/000182256
14. GK Hansson 2005 Inflammation, atherosclerosis, and coronary artery disease NEJM 352 1685 1695 15843671 10.1056/NEJMra043430 1:CAS:528: DC%2BD2MXjsFCltrc%3D (Pubitemid 40530235)
15. D Hürlimann A Forster G Noll, et al. 2002 Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis Circulation 106 2184 2187 12390945 10.1161/01.CIR.0000037521.71373.44 (Pubitemid 35222210)
16. LT Jacobsson C Turesson JA Nilsson IF Petersson E Lindqvist T Saxne P Geborek 2007 Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis Ann Rheum Dis 66 670 675 17158824 10.1136/ard.2006.062497 (Pubitemid 46707138)
17. PA Jansson 2007 Endothelial dysfunction in insulin resistance and type 2 diabetes J Int Med 262 173 183 10.1111/j.1365-2796.2007.01830.x 1:CAS:528:DC%2BD2sXhtVens7nP (Pubitemid 47087632)
18. MT Kearney ER Duncan M Kahn SB Wheatcroft 2008 Insulin resistance and endothelial cell dysfunction; studies in mammalian models Exp Physiol 93 158 163 17933859 10.1113/expphysiol.2007.039172 1:CAS:528:DC%2BD1cXivFKksrc%3D (Pubitemid 350293975)
19. AB Kimball D Gladman JM Gelfand K Gordon EJ Horn NJ Korman G Korver GG Krueger BE Strober MG Lebwohl 2008 National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening J Am Acad Dermatol 58 1031 1042 18313171 10.1016/j.jaad.2008.01.006
20. MA Lazar 2001 The hormone resistin links obesity to diabetes Nature 409 307 312 11201732 10.1038/35053000 (Pubitemid 32151228)
21. RJ Ludwig C Herzog A Rostock FR Ochsendorf TM Zollner D Thaci R Kaufmann TJ Vogl WH Boehncke 2007 Psoriasis: a possible risk factor for development of coronary artery calcification Br J Dermatol 156 271 276 17223866 10.1111/j.1365-2133.2006.07562.x 1:STN:280:DC%2BD2s%2FislaitA%3D%3D (Pubitemid 46095954)
22. RJ Ludwig JE Schultz WH Boehncke M Podda C Tandi F Krombach H Baatz R Kaufmann UH von Andrian TM Zollner 2004 Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing distinct sets of adhesion molecules J Invest Dermatol 122 830 836 15086572 10.1111/j.0022-202X.2004.22318. x 1:CAS:528:DC%2BD2cXjt1SmsLs%3D (Pubitemid 38471355)
23. Martyn-Simmons CL, Ranawaka RR, Chowienczyk P, Crook MA, Marber MS, Smith CH, Barker JN. A prospective case controlled cohort study of endothelial function in patients with moderate to severe psoriasis. Br J Dermatol (e-pub ahead of print)
24. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 3899825 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D (Pubitemid 15018832)
25. O Melander C Newton-Cheh P Almgren B Hedblad G Berglund G Engström M Persson JG Smith M Magnusson A Christensson J Struck NG Morgenthaler A Bergmann MJ Pencina TJ Wang 2009 Novel and conventional biomarkers for prediction of incident cardiovascular events in the community JAMA 302 49 57 19567439 10.1001/jama.2009.943 1:CAS:528:DC%2BD1MXotFKns7o%3D
26. A Nast I Kopp M Augustin KB Banditt WH Boehncke M Follmann the Psoriasis Treatment Guideline Expert Group 2007 German evidence-based guidelines for the treatment of psoriasis vulgaris (short version) Arch Dermatol Res 299 111 138 17497162 10.1007/s00403-007-0744-y 1:STN:280:DC%2BD2szhs1Kqug%3D%3D (Pubitemid 46835379)
27. FO Nestle DH Kaplan JNWN Barker 2009 Psoriasis NEJM 361 496 509 19641206 10.1056/NEJMra0804595 1:CAS:528:DC%2BD1MXpt1Crsb8%3D
28. S Prodanovich F Ma JR Taylor C Pezon T Fasihi RS Kirsner 2005 Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis J Am Acad Dermatol 52 262 267 15692471 10.1016/j.jaad.2004.06.017
29. K Reich U Mrowitz 2007 Treatment goals in psoriasis J Dtsch Dermatol Ges 5 566 574 17610606 10.1111/j.1610-0387.2007.06343.x (Pubitemid 47047228)
30. V Schächinger MB Britten AM Zeiher 2000 Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 1899 1906 10779454 (Pubitemid 30225269)
31. RS Stern 2010 Psoriasis is not a useful independent risk factor for cardiovascular disease J Invest Dermatol 130 917 919 20231828 10.1038/jid.2009.446 1:CAS:528:DC%2BC3cXjsFSkt70%3D
32. T Soeki Y Tamura H Shinohara H Tanaka K Bando N Fukuda 2000 Serial changes in serum VEGF and HGF in patients with acute myocardial infarction Cardiology 93 168 174 10965088 10.1159/000007022 1:CAS:528:DC%2BD3cXmvVSjtr8%3D
33. B Strober C Teller P Yamauchi JL Miller M Hooper YC Yang F Dann 2008 Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis Br J Dermatol 159 322 330 18503600 10.1111/j.1365-2133.2008.08628.x 1:CAS:528:DC%2BD1cXhtVCqs7nI (Pubitemid 352009830)
34. RE Ulusoy O Karabudak M Yokusoglu F Kilicaslan A Kirilmaz BS Cebeci 2010 Noninvasive assessment of impaired endothelial function in psoriasis Rheumatol Int 30 479 483 19529939 10.1007/s00296-009-0995-3
35. K Walsh 2009 Adipokines, myokines and cardiovascular disease Circ J 73 13 18 19043226 10.1253/circj.CJ-08-0961
36. C Weikert S Westphal K Berger J Dierkes M Möhlig J Spranger EB Rimm SN Willich H Boeing T Pischon 2008 Plasma resistin levels and risk of myocardial infarction and ischemic stroke J Clin Endocrinol Metab 93 2647 2653 18460562 10.1210/jc.2007-2735 1:CAS:528:DC%2BD1cXoslyku7o%3D (Pubitemid 352008532)
37. P Weisenseel AV Kuznetsov JP Prinz 2007 Implementation of the S3-guidelines for systemic and UV therapy of moderate to severe psoriasis vulgaris by an algorithm JDDG 5 683 688 17659043 10.1111/j.1610-0387.2007.06378. x (Pubitemid 47099802)
38. R Bissonnette RG Langley K Papp R Matheson D Toth M Hultquist GP Geba B White 2009 Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab Arch Dermatol Res 301 429 442 19471949 10.1007/s00403-009-0961-7 1:CAS:528: DC%2BD1MXnslegsLk%3D
39. LJ Ma Y You BX Bai YZ Li 2009 Therapeutic effects of heme oxygenase-1 on psoriasiform skin lesions in guinea pigs Arch Dermatol Res 301 459 466 19415314 10.1007/s00403-009-0956-4 1:CAS:528:DC%2BD1MXnslegsL0%3D
40. H Morsy S Kamp L Thrane N Behrendt B Saunder H Zayan EA Elmagid GB Jemec 2010 Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity Arch Dermatol Res 302 105 111 19894055 10.1007/s00403-009-1000-4
41. Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Dauden E, Gisondi P, Iversen L, Kemeny L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N (2010) Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. doi: 10.1007/s00403-010-1080-1
42. OH Munz S Sela BS Baker CE Griffiths AV Powles L Fry 2010 Evidence for the presence of bacteria in the blood of psoriasis patients Arch Dermatol Res 302 495 498 20607546 10.1007/s00403-010-1065-0
43. AL Nancy S Yehuda 2009 Prediction and prevention of autoimmune skin disorders Arch Dermatol Res 301 57 64 18815800 10.1007/s00403-008-0889-3
44. JA O'Daly R Lezama J Gleason 2009 Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis Arch Dermatol Res 301 411 427 19294395 10.1007/s00403-009-0940-z
45. L Prpic-Massari M Kastelan 2009 Innate and acquired immunity in psoriasis Arch Dermatol Res 301 195 196 19123005 10.1007/s00403-008-0925-3
46. M Rostami-Yazdi B Clement U Mrowietz 2010 Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients Arch Dermatol Res 302 531 538 20574745 10.1007/s00403-010-1061-4 1:CAS:528:DC%2BC3cXpsFOlsL8%3D